Idiopathic giant cell myocarditis and cardiac sarcoidosis (Q38056618)

27 August 2017

Idiopathic giant cell myocarditis and cardiac sarcoidosis (English)

1 reference

27 August 2017

1 reference

Lori A Blauwet

1

1 reference

PubMed ID

23111533

27 August 2017

Leslie T Cooper

series ordinal

2

1 reference

27 August 2017

1 November 2013

1 reference

27 August 2017

Heart Failure Reviews

1 reference

27 August 2017

18

1 reference

27 August 2017

6

1 reference

27 August 2017

733-746

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-012-9358-3

27 August 2017

0 references

cites work

Giant cell and granulomatous myocarditis

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

21 January 2018

ISOLATED MYOCARDITIS.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

21 January 2018

Myocarditis in autopsy.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Detection of myocardial damage in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac sarcoidosis: a retrospective study of 41 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Giant-cell myocarditis in a newborn with congenital herpes simplex virus (HSV) infection: an immunohistochemical study on the origin of the giant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Giant cell myocarditis due to coxsackie B2 virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Interferon-alpha Induced Sarcoidosis with Cutaneous Involvement along the Lines of Venous Drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Sarcoidosis and hepatitis C: clinical description of 11 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Gene expression in giant cell myocarditis: Altered expression of immune response genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Advances in the genetics of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Toll-like receptor (TLR)-9 genetics and function in sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

When should high-grade heart block trigger a search for a treatable cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Clinicopathological study of fatal myocardial sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Idiopathic giant cell myocarditis--a distinctive clinico-pathological entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Potential of the right ventricular endomyocardial biopsy to diagnose and assist in the management of congestive heart failure: insights from recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Two-dimensional echocardiographic findings in systemic sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Images in cardiology. Cardiac sarcoidosis in a 60 year old woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac transplantation for pediatric giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Pediatric giant cell myocarditis and orbital myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Giant Cell Myocarditis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Ventricular assist surprise: giant cell myocarditis or sarcoidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Outcome of heart transplantation in patients with sarcoid cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Recurrence of cardiac sarcoidosis in a heart transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Sarcoid heart disease: clinical course and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Efficacy of cyclophosphamide in sarcoid radiculomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9358-3

Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry

21 January 2018

1 reference

12 December 2020

Myocarditis of giant-cell type in an infant

1 reference

12 December 2020

Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects

1 reference

12 December 2020

Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis

1 reference

12 December 2020

GIANT-CELL MYOCARDITIS WITH MULTIPLE ORGAN INVOLVEMENT

1 reference

12 December 2020

Histologic and cytokine response to immunosuppression in giant-cell myocarditis

1 reference

12 December 2020

Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression

1 reference

12 December 2020

Resolution of giant cell myocarditis after extended ventricular assistance

1 reference

12 December 2020

Sarcoid heart disease

1 reference

12 December 2020

Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis

1 reference

12 December 2020

Pericardial tamponade in sarcoidosis

1 reference

12 December 2020

Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation

1 reference

12 December 2020

Cardiac sarcoidosis with spontaneous rupture of the right ventricle

1 reference

12 December 2020

Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Long survival with giant cell myocarditis

1 reference

12 December 2020

Giant cell myocarditis triggered by a parvovirus B19 infection

1 reference

12 December 2020

Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.

1 reference

12 December 2020

Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome

1 reference

12 December 2020

Epidemiology of sarcoidosis

1 reference

12 December 2020

Giant cell myocarditis mimicking idiopathic fascicular ventricular tachycardia

1 reference

12 December 2020

Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis

1 reference

12 December 2020

Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies

1 reference

12 December 2020

Fatal giant cell myocarditis after allogeneic bone marrow transplantation

1 reference

12 December 2020

Ventricular tachyarrhythmia due to cardiac sarcoidosis in a child.

1 reference

12 December 2020

Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis

1 reference

12 December 2020

Multisystemic sarcoidosis associated with a second therapy for chronic hepatitis C.

1 reference

12 December 2020

Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids

1 reference

12 December 2020

Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis

1 reference

12 December 2020

HLA and sarcoidosis: new pathogenetic insights

1 reference

12 December 2020

Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block

1 reference

12 December 2020

A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy

1 reference

12 December 2020

Right ventricle-dominant cardiac sarcoidosis with sparing of the left ventricle

1 reference

12 December 2020

Echocardiographic evaluation of patients with systemic sarcoidosis

1 reference

12 December 2020

Subclinical cardiac dysfunction in sarcoidosis

1 reference

12 December 2020

Sarcoidosis: epidemiology and prognosis. A 15-year European study

1 reference

12 December 2020

Cardiac sarcoidosis: spectrum of MRI features

1 reference

12 December 2020

The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis

1 reference

12 December 2020

Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment

1 reference

12 December 2020

Management of cardiac sarcoidosis in the United States: a Delphi study.

1 reference

12 December 2020

Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study

1 reference

12 December 2020

Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis

1 reference

12 December 2020

Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis

1 reference

12 December 2020

1 reference

12 December 2020

Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients

1 reference

12 December 2020

Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis

1 reference

12 December 2020

Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells

1 reference

12 December 2020

Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis

1 reference

12 December 2020

Giant cell versus granulomatous myocarditis

1 reference

12 December 2020

Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device

1 reference

12 December 2020

Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis

1 reference

12 December 2020

Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans

1 reference

12 December 2020

Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway

1 reference

12 December 2020

Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis

1 reference

12 December 2020

Pentoxifylline in treatment of sarcoidosis

1 reference

12 December 2020

Strain difference in rats with experimental giant cell myocarditis

1 reference

12 December 2020

Fatal neurosarcoidosis induced by interferon alpha treatment in chronic hepatitis C

1 reference

12 December 2020

The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Soci

1 reference

12 December 2020

10.1007/S10741-012-9358-3

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

23111533